DE3875762D1 - Adjuvanzienmischung. - Google Patents

Adjuvanzienmischung.

Info

Publication number
DE3875762D1
DE3875762D1 DE8888200443T DE3875762T DE3875762D1 DE 3875762 D1 DE3875762 D1 DE 3875762D1 DE 8888200443 T DE8888200443 T DE 8888200443T DE 3875762 T DE3875762 T DE 3875762T DE 3875762 D1 DE3875762 D1 DE 3875762D1
Authority
DE
Germany
Prior art keywords
adjuvanic
mix
adjuvanic mix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888200443T
Other languages
English (en)
Other versions
DE3875762T2 (de
Inventor
Eric Onno Rijke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE3875762D1 publication Critical patent/DE3875762D1/de
Publication of DE3875762T2 publication Critical patent/DE3875762T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
DE8888200443T 1987-03-17 1988-03-09 Adjuvanzienmischung. Expired - Fee Related DE3875762T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700629 1987-03-17

Publications (2)

Publication Number Publication Date
DE3875762D1 true DE3875762D1 (de) 1992-12-17
DE3875762T2 DE3875762T2 (de) 1993-05-13

Family

ID=19849718

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888200443T Expired - Fee Related DE3875762T2 (de) 1987-03-17 1988-03-09 Adjuvanzienmischung.

Country Status (9)

Country Link
US (1) US5026543A (de)
EP (1) EP0283085B1 (de)
JP (1) JP2562827B2 (de)
DE (1) DE3875762T2 (de)
DK (1) DK167849B1 (de)
ES (1) ES2052685T3 (de)
GR (1) GR3007039T3 (de)
HU (1) HU202119B (de)
ZA (1) ZA881694B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
AU692440B2 (en) * 1993-03-11 1998-06-11 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5891393A (en) * 1996-04-09 1999-04-06 The University Of North Carolina At Chapel Hill Method for the microbial decontamination of blood platelets
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
DE60039754D1 (de) * 1999-03-24 2008-09-18 Polykationische karbohydrate als immunostimulierende mittel in impstoffen
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
CA2513655C (en) 2003-01-21 2011-11-22 Chiron Corporation Use of tryptanthrin compounds for immune potentiation
EP2258365B1 (de) 2003-03-28 2013-05-29 Novartis Vaccines and Diagnostics, Inc. Verwendung von organischen verbindungen zur immunstärkung
EP2277595A3 (de) 2004-06-24 2011-09-28 Novartis Vaccines and Diagnostics, Inc. Verbindungen zur Immunopotenzierung
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
TWI528970B (zh) 2005-12-29 2016-04-11 百靈佳殷格翰家畜藥品公司 多價第二型豬環狀病毒（ｐｃｖ２）免疫組合物及製備該組合物之方法
MX338626B (es) 2005-12-29 2016-04-26 Boehringer Ingelheim Vetmed Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
WO2007109812A2 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
EP2357184B1 (de) 2006-03-23 2015-02-25 Novartis AG Imidazochinoxalinverbindungen als Immunmodulatoren
CA2647100A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Methods for the preparation of imidazole-containing compounds
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) * 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
CA2712006A1 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
AR074506A1 (es) 2008-12-09 2011-01-19 Gilead Sciences Inc Moduladores de los receptores tipo toll
US9603919B2 (en) * 2009-03-31 2017-03-28 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
MY157343A (en) 2009-05-26 2016-05-31 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
JP5886763B2 (ja) 2010-01-28 2016-03-16 アドバンスド バイオニュートリション コーポレーション 生物活性物質を含む乾燥ガラス状組成物
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CA3081072A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
AU2014329524B2 (en) 2013-10-02 2019-01-17 Boehringer Ingelheim Animal Health USA Inc. PCV2 ORF2 protein variant and virus like particles composed thereof
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
AR114911A1 (es) 2018-06-04 2020-10-28 Apros Therapeutics Inc Conjugados peptídicos de tlr7
JP2021535080A (ja) 2018-07-02 2021-12-16 アユヴィス リサーチ インク.Ayuvis Research, Inc. 新規免疫調節小分子

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178350A (en) * 1961-05-15 1965-04-13 Cutler Lab Inc Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3869546A (en) * 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants

Also Published As

Publication number Publication date
EP0283085B1 (de) 1992-11-11
JPS63253032A (ja) 1988-10-20
DE3875762T2 (de) 1993-05-13
ZA881694B (en) 1988-09-06
DK141488D0 (da) 1988-03-15
DK141488A (da) 1988-09-18
GR3007039T3 (de) 1993-07-30
JP2562827B2 (ja) 1996-12-11
ES2052685T3 (es) 1994-07-16
HUT47224A (en) 1989-02-28
DK167849B1 (da) 1993-12-27
EP0283085A1 (de) 1988-09-21
HU202119B (en) 1991-02-28
US5026543A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
DE3875762D1 (de) Adjuvanzienmischung.
DE3782044T2 (de) Mischapparat.
DE3862564D1 (de) Erdanker.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
IT8821018A0 (it) Proietto.
NO893535D0 (no) Vaskemiddelblanding.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
NO882339L (no) Rensemiddelblanding.
DE3876304T2 (de) Polysilacylobutasilazane.
NO881526L (no) Vaskemiddelblanding.
KR890700391A (ko) 혼합기
DE3870513D1 (de) Tennisball.
FI882074A (fi) Fosfatfri tvaettmedelhjaelpfoerening.
FI90671C (fi) Sekoitin
DE3862309D1 (de) Aminomethyltetrahydrofurane.
DE3780608D1 (de) Knetmischer.
FI880563A0 (fi) Bicykliska beta -laktamkarboxylsyror.
NO882050L (no) Vaskemiddelblanding.
DE3866770D1 (de) Gerbstoff.
DE3873615T2 (de) Polycyanoarylthioether.
DE3867805D1 (de) Paraocclusaler loeffel.
NO884793D0 (no) Blandebatteri.
NO871005D0 (no) Offshore-laste/losse-system.
DE3886353D1 (de) Mischvorrichtung.
DE3875119D1 (de) Sportschuh.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8339 Ceased/non-payment of the annual fee